Synthesis and Anticholinesterase Activity of (-)-Physostigmine Analogues with Modifications at C3a and C5

A new series of physostigmine analogues 3a--3j with modifications at the C3a and C5 positions was de- signed and synthesized. Bioassay of the synthetic analogues 3a--3j, along with the previous synthesized C3a-ethyl-C5-triazole physostigmine analogues laJlg and 2a--2j was performed, which indicates...

Full description

Saved in:
Bibliographic Details
Published inChemical research in Chinese universities Vol. 29; no. 5; pp. 888 - 893
Main Authors Wang, Hui-jing, Zhang, Dan, Wang, Fu-sheng, Wu, Yi, Song, Hao
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer Berlin Heidelberg 01.10.2013
Innovative Drug Research Center, Chongqing University, Chongqing 401331, P.R.China%Key Laboratory of Drug Targeting and Novel Delivery System of the Ministry of Education,West China School of Pharmacy, Sichuan University, Chengdu 610041, P.R.China
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A new series of physostigmine analogues 3a--3j with modifications at the C3a and C5 positions was de- signed and synthesized. Bioassay of the synthetic analogues 3a--3j, along with the previous synthesized C3a-ethyl-C5-triazole physostigmine analogues laJlg and 2a--2j was performed, which indicates that the replace- ment of the carbamoyl moiety of C3a-ethyl-C5-triazole analogues 1 and 2 with a triazole moiety decreased acetyl- cholinesterase(AchE) inhibitory activity, whereas the introduction of heterocycles into the triazole ring increased both AChE and butyrylcholinesterase(BchE) inhibitory activities. Structure-activity relationship(SAR) studies of C3a-methyl-C5-triazole analogues 3 reveal the C3a-methyl substituent is important for AChE and BChE inhibition and the introduction of a second ionizable N center improved the binding of the synthetic analogues to both AChE and BChE.
Bibliography:C3a-ethyl-C5-triazole physostigmine analogue; C3a-methyl-C5-triazole physostigmine analogue; Anti-cholinesterase activity; Alzheimer's disease
A new series of physostigmine analogues 3a--3j with modifications at the C3a and C5 positions was de- signed and synthesized. Bioassay of the synthetic analogues 3a--3j, along with the previous synthesized C3a-ethyl-C5-triazole physostigmine analogues laJlg and 2a--2j was performed, which indicates that the replace- ment of the carbamoyl moiety of C3a-ethyl-C5-triazole analogues 1 and 2 with a triazole moiety decreased acetyl- cholinesterase(AchE) inhibitory activity, whereas the introduction of heterocycles into the triazole ring increased both AChE and butyrylcholinesterase(BchE) inhibitory activities. Structure-activity relationship(SAR) studies of C3a-methyl-C5-triazole analogues 3 reveal the C3a-methyl substituent is important for AChE and BChE inhibition and the introduction of a second ionizable N center improved the binding of the synthetic analogues to both AChE and BChE.
22-1183/06
ISSN:1005-9040
2210-3171
DOI:10.1007/s40242-013-3066-y